Journals / ESTÜDAM Halk Sağlığı Dergisi / 2020 / Cilt: 5 - COVID-19 Özel Sayısı

CLINICAL, LABORATORY AND RADIOLOGICAL FEATURES OF COVID-19

COVID-19’UN KLİNİK, LABORATUVAR VE RADYOLOJİK ÖZELLİKLERİ

Pages
61–69
Publication Date
2020-09-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Protection from infection is the most effective method to prevent the spread of the disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The world was faced with a pandemic that spread from China and left its mark after 2020.
📊
Key Findings & Data:This disease, caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), called coronavirus disease-19 (COVID-19), continues to show its effect.
💡
Conclusion & Impact:Protection from infection is the most effective method to prevent the spread of the disease.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:SARS-CoV-2 · COVID-19'un kliniği · COVID-19'un laboratuvar bulguları

Abstract

The world was faced with a pandemic that spread from China and left its mark after 2020. This disease, caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), called coronavirus disease-19 (COVID-19), continues to show its effect. Patients may exhibit a severe clinical picture that may result in mortality from asymptomatic infection. Common laboratory findings include a decrease in lymphocyte count, an increase in liver enzymes, lactate dehydrogenase and inflammation markers such as ferritin, C-reactive protein and erythrocyte sedimentation rate. In COVID-19 pneumonia, similar to other viral pneumonia, bilateral, middle-lower zones, peripherally located ground-glass opacities with consolidation are the most common findings. There is no consensus treatment yet, and vaccination studies continue in many parts of the world. Protection from infection is the most effective method to prevent the spread of the disease.

Özet

Dünya Çin’den yayılan ve 2020 yılı sonrasına damga vuran bir salgınla karşı karşıya kalmıştır. Ağır akut solunumyolu sendromu koronavirüsü-2 (SARS-CoV-2)’nin neden olduğu ve koronavirüs hastalığı-19 (COVID-19) olarak adlandırılan bu hastalık etkisini göstermeye devam etmektedir. Hastalar asemptomatik enfeksiyondan mortaliteyle sonuçlanabilen ağır bir klinik tablo sergileyebilmektedir. Henüz üzerinde görüş birliği oluşan bir tedavisi olmayıp dünyanın birçok yerinde aşı çalışmaları hızla devam etmektedir. Enfeksiyondan korunma hastalığın yayılmasını önlemede en etkili yöntemdir.

🔖

Cite This Article

AK, G. (2020). CLINICAL, LABORATORY AND RADIOLOGICAL FEATURES OF COVID-19. ESTÜDAM Halk Sağlığı Dergisi, Cilt: 5 - COVID-19 Özel Sayısı, 61–69. https://ajindex.com/articles/905415

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. WHO. Coronavirus disease (COVID-19) pandemic.
  2. Linton NM, Kobayashi T, Yang Y, et al. Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data. J Clin Med. 2020;9(2):538. doi:10.3390/jcm9020538 3. Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med 2020; 382:1199
  3. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382:1708
  4. Zhu J, Zhong Z, Ji P, et al. Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis [published correction appears in Fam Med Community Health. 2020 May;8(2):]. Fam Med Community Health. 2020;8(2):e000406. doi:10.1136/fmch-2020-000406 6. Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill 2020;25(10):2000180
  5. Sutton D, Fuchs K, D'Alton M, Goffman D. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery. N Engl J Med 2020; 382:2163
  6. Oran DP, Topol EJ. Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review. Ann Intern Med 2020;173(5):362-7. doi:10.7326/M20-3012 9. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623. doi:10.1016/j.tmaid.2020.101623 10. Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020;80(6):656-65. doi:10.1016/j.jinf.2020.03.041 11. Loffredo L, Pacella F, Pacella E, Tiscione G, Oliva A, Violi F. Conjunctivitis and COVID-19: A meta-analysis. J Med Virol. 2020;10.1002/jmv.25938. doi:10.1002/jmv.25938 12. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212-3. doi:10.1111/jdv.16387 13. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42
  7. Verity R, Okell LC, Dorigatti I, et al